BROWN RUDNICK LLP for APOTEX CORPORATION
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S. 1882 - Fair and Immediate Release of Generic Drugs Act and P.L. 112 American Taxpayer Relief Act of 2012. Electronic Distribution of Content of Labeling for Human Prescription Drug and Biological Products. (RIN 0910-A618)
Foreign entity interest: ApoSherm Inc., the parent company of Apotex Corp., has direct and/or indirect ownership interest in companies that develop, manufacture, and/or sell generic drugs, and therefore has an interest in the issues identified in this report.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA LAYMAN | SPA, Sen Stabenow(05-07) |
| HENRY W MENN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.